Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma Subcutaneous administration of the anti-CD38 antibody also made for easier dosing Jan 04, 2024
Liso-Cel a Potential New CAR-T Option for High-Risk R/R Follicular Lymphoma Study results show impressive efficacy, favorable safety profile in the second line Jan 04, 2024 video
Futile Immunotherapy for Cancer Grows More Common Occurs most often at non-academic and low-volume centers Jan 04, 2024
Combination Shows Promise in Metastatic ESR1-Mutant Breast Cancer Durable responses with lasofoxifene plus abemaciclib in post-CDK4/6 inhibitor setting Jan 03, 2024
Paramagnetic Seeds: An Effective Option for Breast Lesion Localization Study finds seeds-SPIO combo compares favorably with guidewire-SPIO for breast-conserving surgery Jan 02, 2024
Lessons From the Chemotherapy Shortages: Invest in Generics We need more sustainable solutions to ensure treatment access Dec 31, 2023
Cancer Patients Face Frightening Delays in Treatment Approvals "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
Gene Therapy for Hemophilia Becomes a Reality Uptake of new options for hemophilia A and B has been a bit slow Dec 29, 2023
Financial Toxicity Among Single Mothers With Metastatic Breast Cancer Diagnosis coupled with financial burden makes for a difficult situation, but help is out there Dec 29, 2023 video
Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
Chemo-Free Quadruplet Promising as Initial Treatment in DLBCL Approach could allow for a response-adapted reduction of CHOP Dec 27, 2023 video
Mind of the 'Maestro': Inside the Head of Leonard Bernstein Psychiatrist and concert pianist Richard Kogan, MD, on the great composer's complex inner life Dec 27, 2023
Longer Letermovir Prophylaxis Reduced Risk of Cytomegalovirus Infection After HSCT Randomized study showed extending prophylaxis from 100 to 200 days was effective and safe Dec 27, 2023
Significant Left Nasal Obstruction Finally Diagnosed After 2 Years Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man Dec 26, 2023
Tisa-Cel Yields Durable Responses in R/R Follicular Lymphoma Our panel of experts discuss 3-year findings from the phase II ELARA study Dec 26, 2023 video
SABCS 2023 Highlights Open the Door for More Key Data in 2024 Virginia Kaklamani, MD, discusses this year's sessions of interest and looks ahead to next year Dec 22, 2023 video
Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
Can JAK Inhibition Help Overcome Lenalidomide Resistance in Myeloma? Early-phase experience with ruxolitinib suggests potential role in relapsed/refractory disease Dec 21, 2023 video
Homelessness Tied to Worse Cancer Outcomes Among Veterans However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
Responses to Mosunetuzumab in Follicular Lymphoma Remain Durable at 3 Years Bispecific antibody also shows high response rates in frontline setting Dec 20, 2023 video
Positive Results for Odronextamab in Relapsed/Refractory DLBCL But experts aren't sure where it would fit in with currently approved bispecifics Dec 20, 2023 video
'Curable': A Case for Precision of Language Patients need a clear description of their prognosis Dec 19, 2023
Psilocybin May Help Ease Depression in Cancer Patients In small trial, half had early remission of depressive symptoms after psilocybin-assisted therapy Dec 18, 2023
National Database Study Finds Higher Risk for Barrettβs Esophagus in IBD But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
The 'Before and After': An Eye Surgeon's Unexpected Finding There are a few possible diagnoses in patient with headaches, blurred vision, but one stands out Dec 16, 2023
FDA Approves New First-Line Standard of Care in Bladder Cancer Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma Phase II findings on golidocitinib will form the basis of an accelerated approval application Dec 15, 2023
Hematocrit Stabilized in Polycythemia Vera Treated With Novel Hepcidin Mimetic Rusfertide maintained hematocrit Dec 15, 2023
Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC But editorialists note that with recent advances, "it is hard to justify" use of combination Dec 15, 2023
FDA Approves Belzutifan for Advanced Renal Cell Carcinoma HIF-2 inhibitor indicated for patients who progress after immunotherapy and anti-VEGF Dec 15, 2023
Why Some Myeloma Patients Refuse Stem Cell Transplant Study shows the various factors behind refusal of autologous stem cell transplantation Dec 15, 2023 video
'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer Our panel of experts discuss the latest data from various ongoing trials Dec 14, 2023 video
Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trials News, features, and commentary about cancer-related issues Dec 14, 2023
FDA OKs Maintenance Option for High-Risk Neuroblastoma Eflornithine approved to reduce relapse risk in both kids and adults Dec 14, 2023
Ibrutinib-Venetoclax Improves PFS in R/R Mantle Cell Lymphoma Will results revive ibrutinib role in MCL following withdrawal of accelerated approval? Dec 13, 2023
'Half-Matched' BMTs Effective in Severe Sickle Cell Disease High survival rates observed in patients not normally suitable for transplant Dec 13, 2023
Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial Numerical advantages in OS, PFS fall short of statistical significance Dec 13, 2023
Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorder 24 weeks of daily treatment significantly reduced recurrent nosebleeds in HHT trial Dec 13, 2023
Early Detection Is Key to Higher Cure Rates in Ovarian Cancer "We are not aware of precancer stages for ovarian cancer" Dec 13, 2023